6,345 followers
By eliminating bias early in the research cycle, important breakthroughs can gain earlier recognition and regulatory approval. https://t.co/8iTiQyNzoH
Canagliflozin lowers blood sugar, but does it also lower cardiovascular risk? Maybe not.
Overview of attention for article published in Annals of Translational Medicine, December 2017
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (85th percentile)
-
High Attention Score compared to outputs of the same age and source (92nd percentile)
Readers on
- mendeley
- 19 Mendeley